Birth-related increase in intracolonic hydrogen gas and nitric oxide as indicator of host-microbial interactions

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 60, Issue 3, 2005, Pages 396-400

  Sobko, T ^a   Norman, M ^a   Norin, E ^b   Gustafsson, L E ^a   Lundberg, J O ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Allergy; Biomarker; Intestinal microflora; Mode of delivery; Newborn infant; Short chain fatty acids

Indexed keywords

HYDROGEN; NITRIC OXIDE; SHORT CHAIN FATTY ACID;

ALLERGY; ARTICLE; BIRTH; CESAREAN SECTION; COLON; DIAGNOSTIC VALUE; DISEASE MARKER; FECES ANALYSIS; FEMALE; HOST PATHOGEN INTERACTION; HUMAN; HUMAN EXPERIMENT; INFANT; INTESTINE FLORA; INTESTINE MUCOSA; MALE; MEASUREMENT; MICROBIAL COLONIZATION; MINIMALLY INVASIVE SURGERY; NEWBORN; NORMAL HUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; SAMPLING; VAGINAL DELIVERY;

AGING; BACTERIA; COLON; FATTY ACIDS, VOLATILE; FECES; FEMALE; GASES; HUMANS; HYDROGEN; INFANT, NEWBORN; MALE; NITRIC OXIDE; PARTURITION; TIME FACTORS;

EID: 14344266293     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2005.00737.x     Document Type: Article

References (23)

1. Wiedermann U. Mucosal immunity-mucosal tolerance. A strategy for treatment of allergic diseases. Chem Immunol Allergy 2003;82:11-24.
2. Kirjavainen PV, Gibson GR. Healthy gut microflora and allergy: factors influencing development of the microbiota. Ann Med 1999;31:288-292.
3. Rognum TO, Thrane S, Stoltenberg L, Vege A, Brandtzaeg P. Development of intestinal mucosal immunity in fetal life and the first postnatal months. Pediatr Res 1992;32:145-149.
4. Cook SI, Sellin JH. Review article: Short chain fatty acids in health and disease. Aliment Pharmacol Ther 1998;12:499-507.
5. Cummings JH, Englyst HN. Fermentation in the human large intestine and the available substrates. Am J Clin Nutr 1987;45(Suppl. 5):1243-1255.
6. McNeil NI. The contribution of the large intestine to energy supplies in man. Am J Clin Nutr 1984;39:338-342.
7. Lundberg JO, Lundberg JM, Alving K, Weitzberg E. Nitric oxide and inflammation: the answer is blowing in the wind. Nat Med 1997;3:30-31.
8. Lundberg JO, Hellstrom PM, Lundberg JM, Alving K. Greatly increased luminal nitric oxide in ulcerative colitis. Lancet 1994;344:1673-1674.
9. Lundberg JO, Herulf M, Olesen M, Bohr J, Tysk C, Wiklund NP et al. Increased nitric oxide production in collagenous and lymphocytic colitis. Eur J Clin Invest 1997;27:869-871.
10. Herulf M, Ljung T, Hellstrom PM, Weitzberg E, Lundberg JO. Increased luminal nitric oxide in inflammatory bowel disease as shown with a novel minimally invasive method. Scand J Gastroenterol 1998;33:164-169.
11. Midtvedt AC, Midtvedt T. Production of short chain fatty acids by the intestinal microflora during the first 2 years of human life. J Pediatr Gastroenterol Nutr 1992;15:395-403.
12. Ljung T, Beijer E, Herulf M, Weitzberg E, Lundberg JO, Finkel Y et al. Increased rectal nitric oxide in children with active inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2002;34:302-306.
13. Gronlund MM, Lehtonen OP, Eerola E, Kero P. Fecal microflora in healthy infants born by different methods of delivery: permanent changes in intestinal flora after cesarean delivery. J Pediatr Gastroenterol Nutr 1999;28:19-25.
14. Neut C, Bezirtzoglou E, Romond C, Beerens H, Delcroix M, Noel AM. Bacterial colonization of the large intestine in newborns delivered by cesarean section. Zentralbl Bakteriol Mikrobiol Hyg [A] 1987;266:330-337.
15. 2 from glucose by the fecal flora of a 16- to 158-d-old breast-fed infant. J Nutr 1998;128:85-90.
16. Bennet RC, Nord E. Development of the faecal anaerobic microflora after caesarean section and treatment with antibiotics in newborn infants. Infection 1987;15:332-336.
17. Singer II, Kawka DW, Scott S, Weidner JR, Mumford RA, Riehl TE et al. Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology 1996;111: 871-885.
18. Vidai K, Labeta MO, Schiffrin EJ, Donnet-Hughes A. Soluble CD14 in human breast milk and its role in innate immune responses. Acta Odontol Scand 2001;59:330-334.
19. Weitzberg EJ, Lundberg O. Nonenzymatic nitric oxide production in humans. Nitric Oxide 1998;2:1-7.
20. Herulf M, Blomquist L, Ljung T, Weitzberg E, Lundberg JO. Increased rectal nitric oxide in coeliac disease after local challenge with gluten. Scand J Gastroenterol 2001;36:169-173.
21. Mourad FH, Turvill JL, Farthing MJ. Role of nitric oxide in intestinal water and electrolyte transport. Gut 1999;44:143-147.
22. Mashimo H, Kjellin A, Goyal RK. Gastric stasis in neuronal nitric oxide synthase-deficient knockout mice. Gastroenterology 2000;119:766-773.
23. Taylor-Robinson AW, Liew FY, Severn A, Xu D, McSorley SJ, Garside P et al. Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells. Eur J Immunol 1994;24:980-984.